Characteristics | Category | Follow-up outcome | |
---|---|---|---|
LTFU n (%) | Censored n (%) | ||
Age | Continuous | 122 (9.1) | 1219 (90.1) |
Sex (n = 1341) | Male | 83 (6.2) | 704 (52.5) |
Female | 39 (2.9) | 505 (37.7) | |
Residence (n = 1341) | Urban | 66 (4.9) | 838 (62.5) |
Rural | 56 (4.2) | 380 (28.3) | |
Patient category (n = 1341) | New | 106 (7.9) | 1056 (78.7) |
Relapse | 4 (0.3) | 31 (2.3) | |
Failure | 0 (0) | 3 (0.2) | |
Transferred in | 12 (0.9) | 129 (9.6) | |
Distance (n = 1340) | ≤10 km | 73 (5.4) | 1071 (79.9) |
> 10 km | 49 (3.7) | 147 (11.0) | |
Drug intensive (n = 1341 | RHZE | 120 (8.9) | 1210 (90.3) |
RHZ | 2 (0.1) | 9 (0.7) | |
Drug continuous (n = 1322) | EH | 47 (3.6) | 410 (31.0) |
EH and RH | 2 (0.2) | 33 (2.4) | |
RH | 65 (4.9) | 765 (57.9) | |
CPT provision at enrolment (n = 230) | Yes | 19 (8.3) | 182 (79.1) |
No | 6 (2.6) | 23 (10.0) | |
TB type (n = 1341) | P/pose | 47 (3.5) | 416 (31.0) |
P/negative | 51 (3.8) | 459 (34.2) | |
EP | 24 (1.8) | 344 (25.7) | |
Treatment phase (n = 1341) | Intensive | 85 (6.3) | 99 (7.4) |
Continuous | 41 (3.1) | 1116 (83.2) | |
HIV sero status (n = 1341) | Reactive | 36 (2.7) | 196 (14.6) |
Non-reactive | 85 (6.3) | 1022 (76.2) | |
ART linkage status (n = 234) | On ART | 12 (5.1) | 170 (72.6) |
Not on ART | 19 (8.1) | 33 (14.1) | |
Type of health facility (n = 1341) | Health center | 84 (6.3) | 530 (39.5) |
Hospital | 38 (2.8) | 689 (51.4) |